1. Home
  2. DYN vs PSNY Comparison

DYN vs PSNY Comparison

Compare DYN & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • PSNY
  • Stock Information
  • Founded
  • DYN 1984
  • PSNY 2017
  • Country
  • DYN United States
  • PSNY Sweden
  • Employees
  • DYN N/A
  • PSNY N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • PSNY Auto Manufacturing
  • Sector
  • DYN Health Care
  • PSNY Consumer Discretionary
  • Exchange
  • DYN Nasdaq
  • PSNY Nasdaq
  • Market Cap
  • DYN 2.6B
  • PSNY 2.8B
  • IPO Year
  • DYN 2020
  • PSNY N/A
  • Fundamental
  • Price
  • DYN $25.95
  • PSNY $0.87
  • Analyst Decision
  • DYN Strong Buy
  • PSNY Hold
  • Analyst Count
  • DYN 11
  • PSNY 8
  • Target Price
  • DYN $51.18
  • PSNY $1.59
  • AVG Volume (30 Days)
  • DYN 836.3K
  • PSNY 5.4M
  • Earning Date
  • DYN 11-12-2024
  • PSNY 02-10-2025
  • Dividend Yield
  • DYN N/A
  • PSNY N/A
  • EPS Growth
  • DYN N/A
  • PSNY N/A
  • EPS
  • DYN N/A
  • PSNY N/A
  • Revenue
  • DYN N/A
  • PSNY $2,046,740,000.00
  • Revenue This Year
  • DYN N/A
  • PSNY $40.97
  • Revenue Next Year
  • DYN N/A
  • PSNY $94.45
  • P/E Ratio
  • DYN N/A
  • PSNY N/A
  • Revenue Growth
  • DYN N/A
  • PSNY N/A
  • 52 Week Low
  • DYN $11.66
  • PSNY $0.61
  • 52 Week High
  • DYN $47.45
  • PSNY $2.56
  • Technical
  • Relative Strength Index (RSI)
  • DYN 38.55
  • PSNY 29.95
  • Support Level
  • DYN $25.27
  • PSNY $1.02
  • Resistance Level
  • DYN $28.96
  • PSNY $1.21
  • Average True Range (ATR)
  • DYN 1.41
  • PSNY 0.07
  • MACD
  • DYN -0.23
  • PSNY -0.01
  • Stochastic Oscillator
  • DYN 14.25
  • PSNY 5.52

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.

Share on Social Networks: